Reviewer's report
Title:Efficacy of bevacizumab and chemotherapy in the first-line treatment of
metastatic colorectal cancer: broadening KRAS-focused clinical view
Version:3Date:28 February 2015
Reviewer: Sina Vatandoust
Reviewer's report:
All the comments made in the first review have been accepted by the authors
and the text has been amended accordingly.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests
Reviewer's report
Title:Efficacy of bevacizumab and chemotherapy in the first-line treatment of
metastatic colorectal cancer: broadening KRAS-focused clinical view
Version:3Date:28 February 2015
Reviewer: Sina Vatandoust
Reviewer's report:
All the comments made in the first review have been accepted by the authors
and the text has been amended accordingly.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests
Please review this paper.
user
Reviewer's report
Title:Efficacy of bevacizumab and chemotherapy in the first-line treatment of
metastatic colorectal cancer: broadening KRAS-focused clinical view
Version:3Date:28 February 2015
Reviewer: Sina Vatandoust
Reviewer's report:
All the comments made in the first review have been accepted by the authors
and the text has been amended accordingly.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: No, the manuscript does not need to be seen by a statistician.
Declaration of competing interests:
I declare that I have no competing interests
assistant